Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients

ABSTRACT Objective To evaluate melatonin secretion in adult hypopituitary patients with Growth Hormone deficiency (AGHD) on and off replacement therapy. Subjects and methods We studied 48 subjects: 12 (6 males) untreated AGHD (AGHDnt), 20 (10 males) treated AGHD (AGHDt) and 16 healthy subjects (8 males) as control group (CG). We measured urinary 6-sulfatoxymelatonin (6-SM) in total (24 h samples), nocturnal (6-SMn): 1800-0800 and diurnal samples (6-SMd): 0800-1800. Results Significant differences were observed among the 3 groups of male subjects, in total 6-SM (p < 0.05), nocturnal 6-SM (p < 0.02) and nighttime-daytime delta values (p < 0.003). CG had significantly higher values than the AGHDnt in total 6-SM (p < 0.01), nocturnal 6-SM (p < 0.05) and nighttime-daytime delta values (p < 0.01). AGHDt patients showed significantly higher levels in nighttime-daytime delta values than AGHDnt patients (p < 0.05). In females, no significant differences were found among the 3 groups studied in total, nocturnal, diurnal or nighttime-daytime delta values. In males, significant correlations were found among total 6-SM (r = 0.58; p = 0.029), nocturnal 6-SM (r = 0.70; p = 0.006) and nighttime-daytime delta values (r = 0.71; p = 0.004) vs. serum IGF-1 levels in subjects evaluated. In females, significant correlations were found among total 6-SM (r = 0.57; p = 0.02) vs. serum IGF-1 levels in subjects evaluated. A tendency towards a significant correlation was found in diurnal 6-SM (r = 0.48; p = 0.07). Conclusions Our findings show a sexual dimorphism in 6-SM excretion in AGHD patients and provide an interesting approach to a further understanding of some chronobiological disorders involved in GH deficiency.

Modulation of pineal activity during the 23rd sunspot cycle: Melatonin rise during the ascending phase of the cycle is accompanied by an increase of the sympathetic tone.

In two groups of female CD-rats nocturnal urine (19-23 h, 23-3 h, 3-7 h) was collected at monthly intervals over 658 days (I: 1997-1999) and 494 days (II: 1999-2000) coinciding with the ascending limb (1996-2000) of the 23rd sunspot cycle (1996-2008). The excretion of 6-sulfatoxymelatonin (aMT6s: I, II) was determined as well as the ratio of noradrenaline/adrenaline (NA/A: I) reflecting the activity of the sympathetic nervous system. AMT6s was higher in II than I (19-7 h: +24%; P<0.001; 23-3 h: +30% and 3-7 h: +17%, P<0.001), and progressively increased (19-23 h) showing linear regressions (I: R=+0.737, P=0.003; II: R=+0.633, 0.008) which correlated (I) with the Planetary Index (Ap: R=+0.598, P=0.020), an established estimate of geomagnetic disturbances due to solar activity. NA/A rose at all intervals (I: 46-143%) correlating with Ap (R=+0.554-0.768; P=0.0399-0.0013). These results indicate that melatonin secretion rises as solar activity increases during the ascending limb of a sunspot cycle accompanied by growing geomagnetic disturbances (Ap) which elevate the sympathetic tone and thus affect the pineal gland, initially stimulating the activity of arylalkylamine N-acetyltransferase and subsequently fostering the expression of N-acetylserotonin O-methyltransferase (rate-limiting enzyme for melatonin biosynthesis) if Ap increases further. The potential (patho) physiological significance of these findings is discussed and the need for a systematic continuation of such studies is emphasized.

Self-Reported Sleep Latency in Postmenopausal Women

The aim of this study was to access how self-reported sleep latency (SRSL) was affected by sleep habits, mood, and circadian rhythm in postmenopausal women. Subjects (n=384, 67.9+/-7.7 yr) completed sleep and mood questionnaires, sleep log and actigraphic data. The major urinary melatonin metabolite (6-sulphatoxymelatonin, aMT6s) was assayed in fractional urine specimens for two 24-hr intervals. Although SRSL (26.5+/-24.4 min) and actigraphic sleep latency (ASL; 27.8+/-20.0 min) were correlated (rs=0.361, p<0.001), the short SRSLs tended to be underestimated whereas the long SRSLs tended to be overestimated as compared to ASL. SRSL was positively correlated with the scales of insomnia, mood and hot flash, hypertension, use of anti-hypertensive drugs and the acrophase and the offset of aMT6s. SRSL was negatively correlated with the global assessment of functioning scale in DSM-IV (GAF scale), and light exposure and wrist activity. Multiple linear regression analysis showed that the best-fit model to predict SRSL was light exposure, GAF scale, and use of anti-hypertensive drugs. SRSL may be determined by psychophysiological factors as well as circadian rhythm function. Therapeutic approaches suggested for trouble falling asleep might include increased daylight exposure, improvements in general health, and modification of anti-hypertensive pharmacotherapy.

Melatonin binding sites in interstitial cells from immature rat testes

Melatonin binding sites in rat testes interstitial cells were identified using 2-[125I]-iodomelatonin. Saturation studies of cells revealed a single class of high affinity binding sites, with an apparent equilibrium dissociation constant (Kd) of 100 +/- 20 pM, and a total binding capacity (B max) of 3.0 +/- 0.2 x 10(3) melatonin molecules per cell. Binding was reversible and inhibited by non radioactive melatonin. These results suggest that interstitial cells from immature rat testes have specific receptors for melatonin